The replication crisis in economics – and how we might answer it

On September 8, 2017 the ZBW Leibniz Information Center for Economics hosted the workshop “Replications in Empirical Economics – Ways out of the Crisis” at the Annual Conference of the Verein für Socialpolitik in Vienna, Austria. Thirty participants and four speakers engaged in lively and stimulating discussions about replications and the publication of replications in Economics.

This is a cross-post of the weblog of the replication network. Read the rest of this entry »

Article: The Economics of Reproducibility in Preclinical Research

In 2012, an estimated 114.8 billion $ in the US were spent on life sciences research. Roughly half of it is spent on preclinical research, with government sources providing the majority of funding – approximatly 38 billion US$.

Now, three researchers calculate the costs of irreproducible research in preclinical research near 28 billion $ – only for the United States alone. That is the conclusion of a study published in PLoS Biology a few days ago.

In the opinion of the study’s authors, the giant amount of 28 billion $ accumulates, because low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development.

Read the rest of this entry »

SageCite-Project releases interviews with biosciences editors on citing and linking data

The SageCite project, funded by JISC, is releasing interviews with the editors of two leading journals in the Biosciences.  The two interviews explore a large range of issues concerning data, scholarly communications and publishers, the links between data and publications and interoperability between data repositories and publishers.